Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis.

Authors:
Arai T; Hirose M; Hamano Y; Kagawa T; Murakami A and 3 more

Journal:
Can Respir J

Publication Year: 2022

DOI:
10.1155/2022/1107673

PMCID:
PMC8983265

PMID:
35391716

Journal Information

Full Title: Can Respir J

Abbreviation: Can Respir J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of Interest AM is an employee of Medical and Biological Laboratory Co., Ltd. (MBL). The study was performed in collaboration between the authors' institutions and MBL. YI is an advisor to Boehringer Ingelheim, Taiho, Roche, and SAVARA. YI has received lecture fees from Boehringer Ingelheim, Shionogi, and GSK. TA has received lecture fees from Boehringer Ingelheim and Shionogi for activities not connected with the submitted work. MH, YH, TK, HK, and AK declare that they have no conflicts of interest."

Evidence found in paper:

"The authors are grateful to Dr. Masanori Kitaichi for the pathological examinations and Dr. Masanori Akira for the radiological evaluations. This study was partially supported by JSPS KAKENHI (JP17K09636) awarded to TA, YI, and MH, a National Hospital Organization (H28-NHO (Kokyu)-2) grant awarded to TA and YI, and AMED grants (DLD/14526278 and PAP/14526182) awarded to YI and to YI and TA, respectively."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025